“BONEBRIDGE Bone Conduction Implant in Adults”
Approximately thirty subjects with mixed or conductive hearing loss, meeting FDAa??cleared candidacy criteria for the BONEBRIDGE, will be implanted and followed for three (3) months posta??activation to assess safety and effectiveness of the BONEBRIDGE implant.
Device - BONEBRIDGE
Bone Conduction Implant
Outcomes in Adults With Mixed or Conductive Hearing Loss Implanted With the BONEBRIDGE